Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear

Science Translational Medicine

Volumn 6, Issue 233, 2014, Pages

  Pinyon, Jeremy L ^a   Tadros, Sherif F ^a   Froud, Kristina E ^a   Wong, Ann C Y ^a   Tompson, Isabella T ^a   Crawford, Edward N ^a   Ko, Myungseo ^a   Morris, Renée ^a   Klugmann, Matthias ^a   Housley, Gary D ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCHLEA PROSTHESIS; COCHLEAR NERVE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTRODE IMPLANT; ELECTROPORATION; EVOKED BRAIN STEM AUDITORY RESPONSE; EX VIVO GENE TRANSFER; GENE THERAPY; GUINEA PIG; IN VIVO GENE TRANSFER; MESENCHYME CELL; NERVE REGENERATION; NONHUMAN; PERCEPTION DEAFNESS; PERILYMPH; PRIORITY JOURNAL; SPIRAL GANGLION; ANIMAL; BIONICS; CYTOLOGY; DEAFNESS; DISEASE MODEL; EAR; ELECTRODE; GENE TRANSFER; GENETIC TRANSFECTION; GENETICS; MESODERM; NEURITE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; BIONICS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COCHLEAR IMPLANTS; DEAFNESS; DISEASE MODELS, ANIMAL; EAR; ELECTRODES; ELECTROPORATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GUINEA PIGS; MESODERM; NERVE REGENERATION; NEURITES; TRANSFECTION;

EID: 84899507779     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3008177     Document Type: Article

References (41)

1. D. I. Nelson, R. Y. Nelson, M. Concha-Barrientos, M. Fingerhut, The global burden of occupational noise-induced hearing loss. Am. J. Ind. Med. 48, 446-458 (2005).
2. J. R. Holt, L. H. Vandenberghe, Gene therapy for deaf mice goes viral. Mol. Ther. 20, 1836-1837 (2012).
3. 2 receptor leads to progressive hearing loss and increased susceptibility to noise. Proc. Natl. Acad. Sci. U.S.A. 110, 2228-2233 (2013).
4. X. Li, K. Nie, N. S. Imennov, J. T. Rubinstein, L. E. Atlas, Improved perception of music with a harmonic based algorithm for cochlear implants. IEEE Trans. Neural Syst. Rehabil. Eng. 21, 684-694 (2013).
5. S. J. O'Leary, R. R. Richardson, H. J. McDermott, Principles of design and biological approaches for improving the selectivity of cochlear implant electrodes. J. Neural Eng. 6, 055002 (2009).
6. D. Ramekers, H. Versnel, W. Grolman, S. F. Klis, Neurotrophins and their role in the cochlea. Hear. Res. 288, 19-33 (2012).
7. S. H. Green, E. Bailey, Q. Wang, R. L. Davis, The Trk A, B, C's of neurotrophins in the cochlea. Anat. Rec. 295, 1877-1895 (2012).
8. Q. Yu, Q. Chang, X. Liu, Y. Wang, H. Li, S. Gong, K. Ye, X. Lin, Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists. J. Neurosci. 33, 13042-13052 (2013).
9. O. Akil, R. P. Seal, K. Burke, C. Wang, A. Alemi, M. During, R. H. Edwards, L. R. Lustig, Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron 75, 283-293 (2012).
10. K. Kawamoto, S. Ishimoto, R. Minoda, D. E. Brough, Y. Raphael, Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J. Neurosci. 23, 4395-4400 (2003).
11. M. Izumikawa,R. Minoda, K. Kawamoto, K. A. Abrashkin, D. L. Swiderski, D. F.Dolan, D. E. Brough, Y. Raphael, Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat. Med. 11, 271-276 (2005).
12. A. K. Wise, C. R. Hume, B. O. Flynn, Y. S. Jeelall, C. L. Suhr, B. E. Sgro, S. J. O'Leary, R. K. Shepherd, R. T. Richardson, Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea. Mol. Ther. 18, 1111-1122 (2010).
13. A. K. Wise, T. Tu, P. J. Atkinson, B. O. Flynn, B. E. Sgro, C. Hume, S. J. O'Leary, R. K. Shepherd, R. T. Richardson, The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection. Hear. Res. 278, 69-76 (2011).
14. P. J. Atkinson, A. K. Wise, B. O. Flynn, B. A. Nayagam, C. R. Hume, S. J. O'Leary, R. K. Shepherd, R. T. Richardson, Neurotrophin gene therapy for sustained neural preservation after deafness. PLOS One 7, e52338 (2012).
15. S. P. Gubbels, D. W. Woessner, J. C. Mitchell, A. J. Ricci, J. V. Brigande, Functional auditory hair cells produced in the mammalian cochlea by in utero gene transfer. Nature 455, 537-541 (2008).
16. M. Parker, A. Brugeaud, A. S. B. Edge, Primary culture and plasmid electroporation of the murine organ of Corti. J. Vis. Exp. 36, 1685 (2010).
17. J. M. Jones, M. Montcouquiol, A. Dabdoub, C. Woods, M. W. Kelley, Inhibitors of differentiation and DNA binding (Ids) regulate Math1 and hair cell formation during the development of the organ of Corti. J. Neurosci. 26, 550-558 (2006).
18. M. Masuda, K. Pak, E. Chavez, A. F. Ryan, TFE2 and GATA3 enhance induction of POU4F3 and myosin VIIa positive cells in nonsensory cochlear epithelium by ATOH1. Dev. Biol. 372, 68-80 (2012).
19. H. Versnel, M. J. Agterberg, J. C. de Groot, G. F. Smoorenburg, S. F. Klis, Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide. Hear. Res. 231, 1-12 (2007).
20. N. Mersmann, D. Tkachev, R. Jelinek, P. T. Röth, W. Möbius, T. Ruhwedel, S. Rühle, W. Weber-Fahr, A. Sartorius, M. Klugmann, Aspartoacylase-lacZ knockin mice: An engineered model of Canavan disease. PLOS One 6, e20336 (2011).
21. J. Gehl, Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scan. 177, 437-447 (1993).
22. S. Orlowski, L. M. Mir, Cell electropermeabilization: A new tool for biochemical and pharmacological studies. Biochim. Biophys. Acta 1154, 51-63 (1993).
23. J. Teissie, M. Golzio, M. P. Rols, Mechanisms of cell membrane electropermeabilization: A minireview of our present (lack of ?) knowledge. Biochim. Biophys. Acta 1724, 270-280 (2005).
24. M. P. Rols, Electropermeabilization, a physical method for the delivery of therapeutic molecules into cells. Biochim. Biophys. Acta 1758, 423-428 (2006).
25. S. I. Sukharev, V. A. Klenchin, S. M. Serov, L. V. Chernomordik, A. Chizmadzhev Yu, Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores. Biophys. J. 63, 1320-1327 (1992).
26. D. Greenwood, D. J. Jagger, L. Huang, N. Hoya, P. R. Thorne, S. S. Wildman, B. F. King, K. Pak, A. F. Ryan, G. D. Housley, P2X receptor signaling inhibits BDNF-mediated spiral ganglion neuron development in the neonatal rat cochlea. Development 134, 1407-1417 (2007).
27. T. G. Landry, A. K. Wise, J. B. Fallon, R. K. Shepherd, Spiral ganglion neuron survival and function in the deafened cochlea following chronic neurotrophic treatment. Hear. Res. 282, 303-313 (2011).
28. J. M. Miller, C. G. Le Prell, D. M. Prieskorn, N. L. Wys, R. A. Altschuler, Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: Effects of brain-derived neurotrophic factor and fibroblast growth factor. J. Neurosci. Res. 85, 1959-1969 (2007).
29. L. S. Kim, S. W. Jeong, Y. M. Lee, J. S. Kim, Cochlear implantation in children. Auris Nasus Larynx 37, 6-17 (2010).
30. B. C. Thompson, R. T. Richardson, S. E. Moulton, A. J. Evans, S. O'Leary, G. M. Clark, G. G. Wallace, Conducting polymers, dual neurotrophins and pulsed electrical stimulation - Dramatic effects on neurite outgrowth. J. Control. Release 141, 161-167 (2010).
31. D. R. Merrill, M. Bikson, J. G. Jefferys, Electrical stimulation of excitable tissue: Design of efficacious and safe protocols. J. Neurosci. Methods 141, 171-198 (2005).
32. H. L. Fitzsimons, R. J. Bland, M. J. During, Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. Methods 28, 227-236 (2002).
33. 1-antitrypsin in mice. Mol. Ther. 4, 122-129 (2001).
34. M. J. Agterberg, H. Versnel, L. M. van Dijk, J. C. de Groot, S. F. Klis, Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J. Assoc. Res. Otolaryngol. 10, 355-367 (2009).
35. A. H. Nagahara, M. H. Tuszynski, Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat. Rev. Drug Discov. 10, 209-219 (2011).
36. M. S. Hildebrand, S. S. Newton, S. P. Gubbels, A. M. Sheffield, A. Kochhar, M. G. de Silva, H. H. Dahl, S. D. Rose,M. A. Behlke, R. J. Smith, Advances inmolecular and cellular therapies for hearing loss. Mol. Ther. 16, 224-236 (2008).
37. C. Hamani, Y. Temel, Deep brain stimulation for psychiatric disease: Contributions and validity of animal models. Sci. Transl. Med. 4, 142rv8 (2012).
38. B. A. West, R. E. Brummett, D. L. Himes, Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Arch. Otolaryngol. 98, 32-37 (1973).
39. R. T. Richardson, A. K. Wise, B. C. Thompson, B. O. Flynn, P. J. Atkinson, N. J. Fretwell, J. B. Fallon, G. G. Wallace, R. K. Shepherd, G. M. Clark, S. J. O'Leary, Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 30, 2614-2624 (2009).
40. J. M. Cederholm, K. E. Froud, A. C. Wong, M. Ko, A. F. Ryan, G. D. Housley, Differential actions of isoflurane and ketamine-based anaesthetics on cochlear function in the mouse. Hear. Res. 292, 71-79 (2012).
41. H. Aihara, J. Miyazaki, Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867-870 (1998).